Skip to content

Pitch Perfect for Parkinson's

Pitch Perfect for Parkinson's – Effect of a group singing intervention on vocal intensity for speech and voice disorders in people with Parkinson’s disease

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12621000452897
Enrollment
15
Registered
2021-04-19
Start date
2021-03-24
Completion date
2021-07-16
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Utilising group singing intervention via Telehealth, conducted by as Speech Pathologist and a Music Therapist, we aim to improve vocal intensity (as defined by dB SPL) in patients with Parkinson's Disease

Interventions

Participants will attend a series of 8 group singing workshops via Telehealth, over 8 weeks. This will be run by a speech pathologist and a music therapist. Concurrent workshop programs will be conducted for 3 groups of maximum 8 people. Each workshop will involve 25 minutes of physical, breathing and vocal warm-up activities; opportunity for social interaction with other group members/carers; and 25 minutes of choral singing of familiar songs. There will be a session attendance and participati

Participants will attend a series of 8 group singing workshops via Telehealth, over 8 weeks. This will be run by a speech pathologist and a music therapist. Concurrent workshop programs will be conducted for 3 groups of maximum 8 people. Each workshop will involve 25 minutes of physical, breathing and vocal warm-up activities; opportunity for social interaction with other group members/carers; and 25 minutes of choral singing of familiar songs. There will be a session attendance and participation checklist to monitor for adherence. During all vocal tasks shaping and cuing will be provided to ensure healthy vocal quality and emphasising vocal loudness using the cue ‘think LOUD’, known to be effective for improving vocal loudness and intelligibility in people with PD. A pre-assessment battery including repeated baseline will be conducted 1-2 weeks prior to the workshops commencing, repeated 1-2 weeks post workshop completion, and a maintenance assessment at around 10 weeks post workshop completion. All assessments will also be conducted via Telehealth.

Sponsors

Royal Prince Alfred Hospital
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of idiopathic Parkinson’s disease 2. Functional English language skills 3.Sufficient access to technology to access videoconferencing software and apps, and sufficient skills in independent use, or access to a regular support person that has skills in its use. 4. Self-reported voice and/or speech changes related to PD diagnosis 5. Stable on current PD medications 6. Willingness to provide informed consent and willingness to participate with the study requirements.

Exclusion criteria

1. Participating in other speech pathology intervention during the study period. 2. Concomitant neurological condition, e.g. stroke, dementia, that have a known impact on communication skills. 3. Known laryngeal pathology.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026